Inhibition of advanced glycation end products (AGEs) accumulation by pyridoxamine modulates glomerular and mesangial cell estrogen receptor α expression in aged female mice

Simone Pereira-Simon, Gustavo A. Rubio, Xiaomei Xia, Weijing Cai, Rhea Choi, Gary E. Striker, Sharon Elliot

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Age-related increases in oxidant stress (OS) play a role in regulation of estrogen receptor (ER) expression in the kidneys. In this study, we establish that in vivo 17β-estradiol (E2) replacement can no longer upregulate glomerular ER expression by 21 months of age in female mice (anestrous). We hypothesized that advanced glycation end product (AGE) accumulation, an important source of oxidant stress, contributes to these glomerular ER expression alterations. We treated 19-month old ovariectomized female mice with pyridoxamine (Pyr), a potent AGE inhibitor, in the presence or absence of E2 replacement. Glomerular ERα mRNA expression was upregulated in mice treated with both Pyr and E2 replacement and TGFβ mRNA expression decreased compared to controls. Histological sections of kidneys demonstrated decreased type IV collagen deposition in mice receiving Pyr and E2 compared to placebo control mice. In addition, anti-AGE defenses Sirtuin1 (SIRT1) and advanced glycation receptor 1 (AGER1) were also upregulated in glomeruli following treatment with Pyr and E2. Mesangial cells isolated from all groups of mice demonstrated similar ERα, SIRT1, and AGER1 expression changes to those of whole glomeruli. To demonstrate that AGE accumulation contributes to the observed age-related changes in the glomeruli of aged female mice, we treated mesangial cells from young female mice with AGE-BSA and found similar downregulation of ERα, SIRT1, and AGER1 expression. These results suggest that inhibition of intracellular AGE accumulation with pyridoxamine may protect glomeruli against age-related oxidant stress by preventing an increase of TGFβ production and by regulation of the estrogen receptor.

Original languageEnglish (US)
Article numbere0159666
JournalPLoS One
Volume11
Issue number7
DOIs
StatePublished - Jul 1 2016

Fingerprint

Pyridoxamine
pyridoxamine
Advanced Glycosylation End Products
Mesangial Cells
Estrogen Receptors
mice
glycation
Oxidants
oxidants
cells
receptors
kidneys
Messenger RNA
Collagen Type IV
Kidney
advanced glycation end products
estrogen receptors
Estradiol
placebos
estradiol

ASJC Scopus subject areas

  • Agricultural and Biological Sciences(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

Inhibition of advanced glycation end products (AGEs) accumulation by pyridoxamine modulates glomerular and mesangial cell estrogen receptor α expression in aged female mice. / Pereira-Simon, Simone; Rubio, Gustavo A.; Xia, Xiaomei; Cai, Weijing; Choi, Rhea; Striker, Gary E.; Elliot, Sharon.

In: PLoS One, Vol. 11, No. 7, e0159666, 01.07.2016.

Research output: Contribution to journalArticle

Pereira-Simon, Simone ; Rubio, Gustavo A. ; Xia, Xiaomei ; Cai, Weijing ; Choi, Rhea ; Striker, Gary E. ; Elliot, Sharon. / Inhibition of advanced glycation end products (AGEs) accumulation by pyridoxamine modulates glomerular and mesangial cell estrogen receptor α expression in aged female mice. In: PLoS One. 2016 ; Vol. 11, No. 7.
@article{0be64867d9b24bacaca28344c0829921,
title = "Inhibition of advanced glycation end products (AGEs) accumulation by pyridoxamine modulates glomerular and mesangial cell estrogen receptor α expression in aged female mice",
abstract = "Age-related increases in oxidant stress (OS) play a role in regulation of estrogen receptor (ER) expression in the kidneys. In this study, we establish that in vivo 17β-estradiol (E2) replacement can no longer upregulate glomerular ER expression by 21 months of age in female mice (anestrous). We hypothesized that advanced glycation end product (AGE) accumulation, an important source of oxidant stress, contributes to these glomerular ER expression alterations. We treated 19-month old ovariectomized female mice with pyridoxamine (Pyr), a potent AGE inhibitor, in the presence or absence of E2 replacement. Glomerular ERα mRNA expression was upregulated in mice treated with both Pyr and E2 replacement and TGFβ mRNA expression decreased compared to controls. Histological sections of kidneys demonstrated decreased type IV collagen deposition in mice receiving Pyr and E2 compared to placebo control mice. In addition, anti-AGE defenses Sirtuin1 (SIRT1) and advanced glycation receptor 1 (AGER1) were also upregulated in glomeruli following treatment with Pyr and E2. Mesangial cells isolated from all groups of mice demonstrated similar ERα, SIRT1, and AGER1 expression changes to those of whole glomeruli. To demonstrate that AGE accumulation contributes to the observed age-related changes in the glomeruli of aged female mice, we treated mesangial cells from young female mice with AGE-BSA and found similar downregulation of ERα, SIRT1, and AGER1 expression. These results suggest that inhibition of intracellular AGE accumulation with pyridoxamine may protect glomeruli against age-related oxidant stress by preventing an increase of TGFβ production and by regulation of the estrogen receptor.",
author = "Simone Pereira-Simon and Rubio, {Gustavo A.} and Xiaomei Xia and Weijing Cai and Rhea Choi and Striker, {Gary E.} and Sharon Elliot",
year = "2016",
month = "7",
day = "1",
doi = "10.1371/journal.pone.0159666",
language = "English (US)",
volume = "11",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "7",

}

TY - JOUR

T1 - Inhibition of advanced glycation end products (AGEs) accumulation by pyridoxamine modulates glomerular and mesangial cell estrogen receptor α expression in aged female mice

AU - Pereira-Simon, Simone

AU - Rubio, Gustavo A.

AU - Xia, Xiaomei

AU - Cai, Weijing

AU - Choi, Rhea

AU - Striker, Gary E.

AU - Elliot, Sharon

PY - 2016/7/1

Y1 - 2016/7/1

N2 - Age-related increases in oxidant stress (OS) play a role in regulation of estrogen receptor (ER) expression in the kidneys. In this study, we establish that in vivo 17β-estradiol (E2) replacement can no longer upregulate glomerular ER expression by 21 months of age in female mice (anestrous). We hypothesized that advanced glycation end product (AGE) accumulation, an important source of oxidant stress, contributes to these glomerular ER expression alterations. We treated 19-month old ovariectomized female mice with pyridoxamine (Pyr), a potent AGE inhibitor, in the presence or absence of E2 replacement. Glomerular ERα mRNA expression was upregulated in mice treated with both Pyr and E2 replacement and TGFβ mRNA expression decreased compared to controls. Histological sections of kidneys demonstrated decreased type IV collagen deposition in mice receiving Pyr and E2 compared to placebo control mice. In addition, anti-AGE defenses Sirtuin1 (SIRT1) and advanced glycation receptor 1 (AGER1) were also upregulated in glomeruli following treatment with Pyr and E2. Mesangial cells isolated from all groups of mice demonstrated similar ERα, SIRT1, and AGER1 expression changes to those of whole glomeruli. To demonstrate that AGE accumulation contributes to the observed age-related changes in the glomeruli of aged female mice, we treated mesangial cells from young female mice with AGE-BSA and found similar downregulation of ERα, SIRT1, and AGER1 expression. These results suggest that inhibition of intracellular AGE accumulation with pyridoxamine may protect glomeruli against age-related oxidant stress by preventing an increase of TGFβ production and by regulation of the estrogen receptor.

AB - Age-related increases in oxidant stress (OS) play a role in regulation of estrogen receptor (ER) expression in the kidneys. In this study, we establish that in vivo 17β-estradiol (E2) replacement can no longer upregulate glomerular ER expression by 21 months of age in female mice (anestrous). We hypothesized that advanced glycation end product (AGE) accumulation, an important source of oxidant stress, contributes to these glomerular ER expression alterations. We treated 19-month old ovariectomized female mice with pyridoxamine (Pyr), a potent AGE inhibitor, in the presence or absence of E2 replacement. Glomerular ERα mRNA expression was upregulated in mice treated with both Pyr and E2 replacement and TGFβ mRNA expression decreased compared to controls. Histological sections of kidneys demonstrated decreased type IV collagen deposition in mice receiving Pyr and E2 compared to placebo control mice. In addition, anti-AGE defenses Sirtuin1 (SIRT1) and advanced glycation receptor 1 (AGER1) were also upregulated in glomeruli following treatment with Pyr and E2. Mesangial cells isolated from all groups of mice demonstrated similar ERα, SIRT1, and AGER1 expression changes to those of whole glomeruli. To demonstrate that AGE accumulation contributes to the observed age-related changes in the glomeruli of aged female mice, we treated mesangial cells from young female mice with AGE-BSA and found similar downregulation of ERα, SIRT1, and AGER1 expression. These results suggest that inhibition of intracellular AGE accumulation with pyridoxamine may protect glomeruli against age-related oxidant stress by preventing an increase of TGFβ production and by regulation of the estrogen receptor.

UR - http://www.scopus.com/inward/record.url?scp=84979220836&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84979220836&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0159666

DO - 10.1371/journal.pone.0159666

M3 - Article

C2 - 27428057

AN - SCOPUS:84979220836

VL - 11

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 7

M1 - e0159666

ER -